Position in NSRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,868
+$3,410 QoQ
Shares Held
3,094
+718.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in NSRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,868 | 3,094 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,458 | 378 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $8,252 | 1,241 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||